◀ Back to RAD17

MPST — RAD17

Text-mined interactions from Literome

Nikolova et al., Transpl Immunol 2000 (Body Weight) : RAD at doses of 0.3, 1 and 3 mg/kg per day delayed rejection to 8.5, 18 and 37.5 days MST
Nikolova et al., Transpl Immunol 2001 (Arteritis) : Monotherapy with 10 and 30 mg/kg/day CsA achieved 10 and 22.5 days median survival time (MST), while 0.1, 0.3, 1 and 3 mg/kg/day RAD resulted in 10.5, 20, > 56 and > 56 days MST , respectively